augment cellular immun function earli phase zidovudin treatment aid patient twenty-f patient aid aid clinic trial group protocol low high dosag zidovudin moder transient increas week lymphocyt blastogenesi interferon-gamma ifn-gamma product vitro respons recombin immun simplex viru type antigen therapi natur killer NK lysi uninfect human immunodefici virus-infect cell week ifn-gamma product immun paramet increas number cell week treatment limit efficaci zidovudin treatment aid patient moder temporari increas nonspecif herpesvirus-specif lymphocyt respons NK cell function 